Trial Site Detail
Drug: |
Imatinib + Bevacizumab |
|||
|---|---|---|---|---|
Trial: |
Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Terminated |
|||
Syracuse Hematology-Oncology Associate of Central New York - CCOP5008 Brittonfield Parkway Suite 700 |
Principal Investigator: |
Jeffrey J. Kirshner, MD |
|---|---|
Contact: |
315-472-7504 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Syracuse Hematology-Oncology Associate of Central New York - CCOP Website: |
http://www.hoacny.com/ |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.